[
    {
        "drugresponse_id": "10297",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "3.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10298",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "4.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10299",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "3.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10300",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "5.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10301",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10343",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "3.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10356",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "4.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10357",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "3.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10367",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "5.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10386",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "4.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10394",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "4.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10395",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "5.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10411",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10417",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "3.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10437",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "5.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10440",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "5.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10457",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "3.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10528",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "3.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10530",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "5.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10533",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "3.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10561",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "A388",
        "VALUE": "4.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10574",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "3.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10575",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "3.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10594",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "3.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10612",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10613",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "5.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10614",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "4.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10615",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "5.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10616",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "3.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10617",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "3.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10618",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10619",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "4.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10620",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "4.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10621",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "4.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10622",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "4.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10623",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "4.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10635",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "3.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10644",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "4.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Phosphodiesterase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "5141",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "4.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5142",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "4.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5143",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "4.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5144",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "4.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5145",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5185",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "4.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5198",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5199",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "4.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5209",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "4.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5228",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5235",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "5.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5236",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "4.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5252",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "5.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5258",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "4.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5279",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "5.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5282",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "4.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5299",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "4.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5369",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5371",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5374",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "4.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5405",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "A388",
        "VALUE": "5.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5421",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "4.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5423",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "4.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5444",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "4.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5460",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "4.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5463",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "4.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5464",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "5.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5465",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5466",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "4.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5467",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "4.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5468",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5469",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "4.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5470",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "4.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5471",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "5.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5472",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "4.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5473",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "4.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5474",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5485",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5494",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "4.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5141",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "4.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5142",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "4.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5143",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "4.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5144",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "4.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5145",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5185",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "4.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5198",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5199",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "4.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5209",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "4.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5228",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5235",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "5.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5236",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "4.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5252",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "5.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5258",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "4.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5279",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "5.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5282",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "4.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5299",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "4.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5369",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5371",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5374",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "4.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5405",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "A388",
        "VALUE": "5.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5421",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "4.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5423",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "4.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5444",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "4.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5460",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "4.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5463",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "4.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5464",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "5.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5465",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5466",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "4.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5467",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "4.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5468",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5469",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "4.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5470",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "4.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5471",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "5.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5472",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "4.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5473",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "4.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5474",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5485",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5494",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "4.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "495",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "501",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "6.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "533",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "595",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "597",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "600",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "639",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "641",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "661",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "679",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "680",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "681",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "682",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "683",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "684",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "685",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "686",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "6.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "687",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "698",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "706",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "495",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "501",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "6.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "533",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "595",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "597",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "600",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "639",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "641",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "661",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "679",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "680",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "681",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "682",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "683",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "684",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "685",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "686",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "6.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "687",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "698",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "706",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "495",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "501",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "6.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "533",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "595",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "597",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "600",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "639",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "641",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "661",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "679",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "680",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "681",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "682",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "683",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "684",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "685",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "686",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "6.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "687",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "698",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "706",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "495",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "501",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "6.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "533",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "595",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "597",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "600",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "639",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "641",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "661",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "679",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "680",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "681",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "682",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "683",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "684",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "685",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "686",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "6.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "687",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "698",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "706",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    }
]